Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 21, 2012; 18(43): 6183-6188
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6183
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6183
Telaprevir/boceprevir era: From bench to bed and back
Qiuwei Pan, Maikel P Peppelenbosch, Harry LA Janssen, Robert J de Knegt, Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, 3015 CE Rotterdam, The Netherlands
Author contributions: Pan Q contributed to conception, design, drafting the article and acquisition, interpretation of the data; Peppelenbosch MP, Janssen HLA and de Knegt RJ contributed to interpretation of data and editing the article; all the authors revised and approval of the version to be published.
Supported by Foundation for Liver and Gastrointestinal Research (SLO); and The Netherlands Organisation for Scientific Research (NWO), No. VENI-grant 916-13-032 (to Pan Q)
Correspondence to: Qiuwei Pan, PhD, Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Room L-462, ’s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. q.pan@erasmusmc.nl
Telephone: +31-10-7034545 Fax: +31-10-7032793
Received: August 6, 2012
Revised: September 25, 2012
Accepted: September 28, 2012
Published online: November 21, 2012
Revised: September 25, 2012
Accepted: September 28, 2012
Published online: November 21, 2012
Core Tip